A biotech company has been given permission to try to resurrect the clinically dead
In a controversial move, a US biotechnology company has been given permission to recruit 20 clinically dead patients and try to bring their central nervous system back to life. If they can successfully reanimate parts of the upper spinal cord, where the lower brain stem is located, there’s a possibility that they could kickstart vital body functions such as breathing and heartbeats - something these patients can only do with the help of machines.